EWTX - Regenxbio stock jumps 13% on positive data for DMD drug
2024-03-05 11:03:07 ET
More on Regenxbio
- REGENXBIO Inc. (RGNX) Q4 2023 Earnings Call Transcript
- Regenxbio: Robust Data, Decent Cash, Never Ending Trials, Buying At Dips
- Regenxbio Q4 2023 Earnings Preview
- Regenxbio spikes after trial win for gene therapy in Hunter syndrome
- Seeking Alpha’s Quant Rating on Regenxbio